Evaluating radiotherapy treatment delay using Failure Mode and Effects Analysis (FMEA)
| Autor: | Donald Dobbins, David Albani, Tarun Podder, Tithi Biswas, Zhengzheng Xu, Soyoung Lee, Mitchell Machtay, Rodney J. Ellis |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
medicine.medical_specialty
Risk Assessment 030218 nuclear medicine & medical imaging Time-to-Treatment Workflow 03 medical and health sciences 0302 clinical medicine Neoplasms Radiation oncology medicine Humans Radiology Nuclear Medicine and imaging Computer Simulation Ct simulation Healthcare Failure Mode and Effect Analysis Radiation treatment planning Retrospective Studies business.industry Radiotherapy Planning Computer-Assisted Treatment delay Hematology Oncology Treatment delivery 030220 oncology & carcinogenesis Emergency medicine Radiotherapy treatment business Tomography X-Ray Computed Failure mode and effects analysis |
| Zdroj: | Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 137 |
| ISSN: | 1879-0887 |
| Popis: | Purpose This study identified and evaluated the factors that are responsible for delay in the clinical workflow of radiation therapy, starting from the CT simulation (CT-Sim) to the first fraction of treatment delivery using the Failure Mode and Effects Analysis (FMEA) methodology. Materials and methods A total of 1106 patient cases were retrospectively analyzed using FMEA methodology. For each failure mode (FM), the following factors were rated and discussed by the group: occurrence (O), severity (S), detectability (D), and methods of improvement or mitigation. In addition, two new factors, namely social effect (SE) and economic effect (EE), were introduced to evaluate the impact of FM on the department or hospital. Risk priority number (RPN) and the product of RPN, SE, and EE (i.e. RPNSE-EE) were calculated for each FM. Results Average delay caused by identified FM was 8 days while 76% of the FMs resulted in delay of less than 5 days. The RPN of all the FMs ranged from 4 to 60 with an average value of 18. “Tumor volume, prescription and objective” had the highest average RPN of 23. The majority of FMs with high RPN were identified in “CT-Sim” (RPN: 21.5 ± 11.1; RPNSE-EE: 97.0 ± 46.4) and “treatment planning” (RPN: 20.1 ± 8.1, RPNSE-EE: 152.9 ± 76.5) stages. Conclusion The FMEA enabled identification of the factors that caused delay in the pre-treatment process of radiation therapy. “CT-Sim” and “treatment planning” stages had more FMs with high RPN values which have higher priority for future improvement. Two new factors, SE and EE, were introduced and appeared to be valuable in evaluating the impact of FMs on radiation oncology department or hospital in general. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect